Bolt Biotherapeutics (BOLT) Leases (2020 - 2025)
Bolt Biotherapeutics (BOLT) has disclosed Leases for 6 consecutive years, with $19.2 million as the latest value for Q4 2025.
- Quarterly Leases fell 11.61% to $19.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.2 million through Dec 2025, down 11.61% year-over-year, with the annual reading at $19.2 million for FY2025, 11.61% down from the prior year.
- Leases hit $19.2 million in Q4 2025 for Bolt Biotherapeutics, down from $19.9 million in the prior quarter.
- In the past five years, Leases ranged from a high of $25.2 million in Q3 2021 to a low of $25000.0 in Q2 2021.
- Historically, Leases has averaged $18.8 million across 5 years, with a median of $20.6 million in 2023.
- Biggest five-year swings in Leases: soared 90328.0% in 2022 and later fell 15.71% in 2024.
- Year by year, Leases stood at $24.4 million in 2021, then decreased by 9.71% to $22.1 million in 2022, then decreased by 13.37% to $19.1 million in 2023, then increased by 13.79% to $21.8 million in 2024, then fell by 11.61% to $19.2 million in 2025.
- Business Quant data shows Leases for BOLT at $19.2 million in Q4 2025, $19.9 million in Q3 2025, and $20.5 million in Q2 2025.